XML 14 R5.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance, shares at Dec. 31, 2023   210 298,281    
Balance, amount at Dec. 31, 2023 $ 8,098     $ 305,351 $ (297,253)
Public offering sale of common stock, warrants, and prefunded warrants, net of offering costs, shares     1,871,921    
Public offering sale of common stock, warrants and prefunded warrants, net of offering costs, amount 100,303     100,303  
Exercise of pre-funded warrants, shares     1,178,707    
Exercise of pre-funded warrants 1     1  
Exercise of warrants, shares     12,000    
Exercise of warrants, amount 68     68  
Stock split and fractional shares issued, shares     59,997    
Stock-based compensation expense 1,125     1,125  
Net loss (17,602)       (17,602)
Balance, shares at Dec. 31, 2024   210 3,420,906    
Balance, amount at Dec. 31, 2024 91,993     406,848 (314,855)
Public offering sale of common stock, warrants, and prefunded warrants, net of offering costs, shares     378,346    
Public offering sale of common stock, warrants and prefunded warrants, net of offering costs, amount 23,216     23,216  
Exercise of pre-funded warrants, shares     2,538,799    
Exercise of pre-funded warrants 12     12  
Exercise of warrants, shares     2,976,079    
Exercise of warrants, amount 15,286   $ 1 15,285  
Stock-based compensation expense 19,163     19,163  
Net loss (52,599)       (52,599)
Balance, shares at Dec. 31, 2025   210 9,314,130    
Balance, amount at Dec. 31, 2025 $ 97,071   $ 1 $ 464,524 $ (367,454)